GLP-1 Effects on Insulin and Glucagon in PTDM

Post-transplantation diabetes mellitus (PTDM) develops in 10-15 % of all renal transplant recipients within 10 weeks after transplantation, and has been associated with increased risk of cardiovascula...

Lead sponsor: Oslo University Hospital•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

COMPLETEDPhase 3

Efficacy, Mechanisms and Safety of SGLT2 Inhibitors in Kidney Transplant Recipients

NCT04965935 · Kidney Transplant Recipients, Post-transplant Diabetes Mellitus, and more

COMPLETEDPhase 2

The POWERED Study: Prophylaxis With Metformin to Prevent PTDM

NCT05240274 · Post-transplant Diabetes Mellitus, New Onset Diabetes After Transplant, and more

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 31, 2016Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment24

Start dateOct 2014

Last updatedMar 31, 2016

Condition

Post-transplant Diabetes Mellitus

Locations shown

Oslo University Hospital, Rikshospitalet

Oslo, Oslo

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 31, 2016Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions